Overview
Availability
- Associate Professor David Wyld is:
- Available for supervision
Works
Search Professor David Wyld’s works on UQ eSpace
2019
Journal Article
The iPROMOS protocol: a stepped-wedge study to implement routine patient-reported outcomes in a medical oncology outpatient setting
Roberts, Natasha Anne, Mudge, Alison, Alexander, Kim, Wyld, David and Janda, Monika (2019). The iPROMOS protocol: a stepped-wedge study to implement routine patient-reported outcomes in a medical oncology outpatient setting. BMJ Open, 9 (2) e027046, e027046. doi: 10.1136/bmjopen-2018-027046
2019
Conference Publication
Ontario oncologists' perspectives on addressing potential barriers in the management of patients with neuroendocrine tumors
Fingrut, Warren, Yelamanchili, Radhika, Thawer, Alia, Chan, David, Wyld, David, Singh, Simron and Lo, Dorothy (2019). Ontario oncologists' perspectives on addressing potential barriers in the management of patients with neuroendocrine tumors. 11th Annual Meeting of the North American Neuroendocrine Tumor Society, Seattle, Washington, October 4-6, 2018. Philadelphia, PA, United States: Lippincott Williams & Wilkins. doi: 10.1097/MPA.0000000000001250
2019
Conference Publication
Practice Patterns, Challenges, and the Role of a Shared Care Model in the Management of Neuroendocrine (NET) Patients
Yelamanchili, Radhika, Thawer, Alia, Chan, David, Lo, Dorothy, Singh, Simron, Fingrut, Warren and Wyld, David (2019). Practice Patterns, Challenges, and the Role of a Shared Care Model in the Management of Neuroendocrine (NET) Patients. 11th Annual Meeting of the North American Neuroendocrine Tumor Society, Seattle, Washington, October 4-6, 2018. Philadelphia, PA, United States: Lippincott Williams & Wilkins. doi: 10.1097/MPA.0000000000001250
2019
Conference Publication
Royal Brisbane MedicalOncology Clinic Activity Review
Kuchel, Anna, Kermond, Anna, Lonton, Jennifer, Wyld, David and Eastgate, Melissa (2019). Royal Brisbane MedicalOncology Clinic Activity Review. COSA's 46th Annual Scientific Meeting, Urological cancer; Age and gender in cancer practice; Digital health in cancer, Adelaide, SA Australia, 12–14 November 2019. Chichester, West Sussex United Kingdom: Wiley-Blackwell.
2018
Journal Article
Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma
Kondrashova, Olga, Topp, Monique, Nesic, Ksenija, Lieschke, Elizabeth, Ho, Gwo-Yaw, Harrell, Maria I., Zapparoli, Giada V., Hadley, Alison, Holian, Robert, Boehm, Emma, Heong, Valerie, Sanij, Elaine, Pearson, Richard B., Krais, John J., Johnson, Neil, McNally, Orla, Ananda, Sumitra, Alsop, Kathryn, Hutt, Karla J., Kaufmann, Scott H., Lin, Kevin K., Harding, Thomas C., Traficante, Nadia, Chenevix-Trench, G., Green, A., Webb, P., Gertig, D., Fereday, S., Moore, S. ... Australian Ovarian Cancer Study (AOCS) (2018). Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma. Nature Communications, 9 (1) 3970, 3970. doi: 10.1038/s41467-018-05564-z
2018
Conference Publication
Is survival improving for patients diagnosed with small intestinal neuroendocrine tumours in Queensland?
Moore, Julie, Dunn, Nathan, Tran, Nancy and Wyld, David (2018). Is survival improving for patients diagnosed with small intestinal neuroendocrine tumours in Queensland?. HOBOKEN: WILEY.
2018
Journal Article
Follow-up recommendations for completely resected gastroenteropancreatic neuroendocrine tumors
Singh, Simron, Moody, Lesley, Chan, David L., Metz, David C., Strosberg, Jonathan, Asmis, Timothy, Bailey, Dale L., Bergsland, Emily, Brendtro, Kari, Carroll, Richard, Cleary, Sean, Kim, Michelle, Kong, Grace, Law, Calvin, Lawrence, Ben, McEwan, Alexander, McGregor, Caitlin, Michael, Michael, Pasieka, Janice, Pavlakis, Nick, Pommier, Rodney, Soulen, Michael, Wyld, David and Segelov, Eva (2018). Follow-up recommendations for completely resected gastroenteropancreatic neuroendocrine tumors. JAMA Oncology, 4 (11), 1597-1604. doi: 10.1001/jamaoncol.2018.2428
2018
Conference Publication
Implementing a highly accessible model of screening and assessment in geriatric oncology: Our experience
Bryant, Geoffrey, Thaker, Darshit, Wyld, David, Leach, Justine, Wheatley, Hermione and Garth, Vanessa (2018). Implementing a highly accessible model of screening and assessment in geriatric oncology: Our experience. HOBOKEN: WILEY.
2018
Journal Article
Chemotherapy in patients with unresected pancreatic cancer in Australia: A population-based study of uptake and survival
Dumbrava, Monica I., Burmeister, Elizabeth A., Wyld, David, Goldstein, David, O'Connell, Dianne L., Beesley, Vanessa L., Gooden, Helen M., Janda, Monika, Jordan, Susan J., Merrett, Neil D., Payne, Madeleine E., Waterhouse, Mary A. and Neale, Rachel E. (2018). Chemotherapy in patients with unresected pancreatic cancer in Australia: A population-based study of uptake and survival. Asia Pacific Journal of Clinical Oncology, 14 (4), 326-336. doi: 10.1111/ajco.12862
2018
Journal Article
Maintaining dose intensity of adjuvant chemotherapy in older patients with breast cancer
Ladwa, Rahul, Kalas, Timothy, Pathmanathan, Shivanshan, Woodward, Natasha, Wyld, David and Sanmugarajah, Jasotha (2018). Maintaining dose intensity of adjuvant chemotherapy in older patients with breast cancer. Clinical Breast Cancer, 18 (5), e1181-e1187. doi: 10.1016/j.clbc.2018.04.016
2018
Journal Article
Perceptions of care and patient-reported outcomes in people living with neuroendocrine tumours
Beesley, Vanessa L., Burge, Matthew, Dumbrava, Monica, Callum, Jack, Neale, Rachel E. and Wyld, David K. (2018). Perceptions of care and patient-reported outcomes in people living with neuroendocrine tumours. Supportive Care in Cancer, 26 (9), 3153-3161. doi: 10.1007/s00520-018-4166-5
2018
Journal Article
Correction: Oncology practitioners' perspectives and practice patterns of post-treatment cancer survivorship care in the Asia-Pacific region: Results from the STEP study [BMC Cancer., 17, (2017) (715)] DOI: 10.1186/s12885-017-3733-3
Chan, Raymond Javan, Yates, Patsy, Li, Qiuping, Komatsu, Hiroko, Lopez, Violeta, Thandar, Myat, Chacko, Selva Titus, So, Winnie Kwok Wei, Pongthavornkamol, Kanaungnit, Yi, Myungsun, Pittayapan, Pongpak, Butcon, Jesson, Wyld, David and Molassiotis, Alex (2018). Correction: Oncology practitioners' perspectives and practice patterns of post-treatment cancer survivorship care in the Asia-Pacific region: Results from the STEP study [BMC Cancer., 17, (2017) (715)] DOI: 10.1186/s12885-017-3733-3. BMC Cancer, 18 (1) 240, 1-1. doi: 10.1186/s12885-018-4105-3
2018
Journal Article
Tumor cystic necrosis following peptide receptor radionuclide therapy in neuroendocrine tumors
Ladwa, Rahul, Wen Hong, Hooi, Wyld, David, Pattison, David A. and Burge, Matthew (2018). Tumor cystic necrosis following peptide receptor radionuclide therapy in neuroendocrine tumors. Clinical Nuclear Medicine, 43 (3), 186-187. doi: 10.1097/RLU.0000000000001970
2018
Journal Article
MyD88 and TLR4 expression in epithelial ovarian cancer
Block, Matthew S., Vierkant, Robert A., Rambau, Peter F., Winham, Stacey J., Wagner, Philipp, Traficante, Nadia, Tołoczko, Aleksandra, Tiezzi, Daniel G., Taran, Florin Andrei, Sinn, Peter, Sieh, Weiva, Sharma, Raghwa, Rothstein, Joseph H., Ramón y Cajal, Teresa, Paz-Ares, Luis, Oszurek, Oleg, Orsulic, Sandra, Ness, Roberta B., Nelson, Gregg, Modugno, Francesmary, Menkiszak, Janusz, McGuire, Valerie, McCauley, Bryan M., Mack, Marie, Lubiński, Jan, Longacre, Teri A., Li, Zheng, Lester, Jenny, Kennedy, Catherine J. ... Goode, Ellen L. (2018). MyD88 and TLR4 expression in epithelial ovarian cancer. Mayo Clinic Proceedings, 93 (3), 307-320. doi: 10.1016/j.mayocp.2017.10.023
2018
Conference Publication
A randomized controlled study comparing treatment of gastro-entero-pancreatic neuroendocrine tumors (GEPNET) with 177Lu-DOTATATE alone and in combination with capecitabine
Van der Zwan, W., Wyld, D., Brabander, T., Teunissen, J., Kam, B., MacFarlane, D., Krenning, E., Kwekkeboom, D. and de Herder, W. (2018). A randomized controlled study comparing treatment of gastro-entero-pancreatic neuroendocrine tumors (GEPNET) with 177Lu-DOTATATE alone and in combination with capecitabine. 15th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, 7 - 9 March 2018. Basel, Switzerland: S. Karger AG.
2018
Journal Article
"...My biggest worry now is how my husband is going to cope': women's relational experiences of cancer "care' during illness
Gibson, Alexandra F., Broom, Alex, Kirby, Emma, Wyld, David K. and Lwin, Zarnie (2018). "...My biggest worry now is how my husband is going to cope': women's relational experiences of cancer "care' during illness. Journal of Gender Studies, 27 (8), 901-913. doi: 10.1080/09589236.2017.1340154
2018
Conference Publication
Validation of Abbreviated 177Lu-DOTATATE Renal and Lesional Dosimetry Protocol using Quantitative SPECT
Goodman, Steven , Patford, Shaun , Ladwa, Rahul , Smith, Jye , Wyld, David and Pattison, David A. (2018). Validation of Abbreviated 177Lu-DOTATATE Renal and Lesional Dosimetry Protocol using Quantitative SPECT. 12th Congress of the World Federation of Nuclear Medicine and Biology., Melbourne Australia, 20-24 April 2018.
2018
Conference Publication
Positron Emission Tomography (PET) predictors of tumor response to Peptide Receptor Radionuclide Therapy (PRRT) in metastatic Neuroendocrine Tumors (NET)
Ladwa, R., Pattison, D., Smith, J., Goodman, S., Burge, M., Rose, S., Dowson, N. and Wyld, D. (2018). Positron Emission Tomography (PET) predictors of tumor response to Peptide Receptor Radionuclide Therapy (PRRT) in metastatic Neuroendocrine Tumors (NET). 15th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, 7-9 March 2018. Basel, Switzerland: S. Karger AG.
2018
Journal Article
BRAF mutations in low-grade serous ovarian cancer and response to BRAF inhibition
Moujaber, Tania, Etemadmoghadam, Dariush, Kennedy, Catherine J., Chiew, Yoke-Eng, Balleine, Rosemary L., Saunders, Catherine, Wain, Gerard V., Gao, Bo, Hogg, Russell, Srirangan, Sivatharsny, Kan, Casina, Fereday, Sian, Traficante, Nadia, Patch, Ann-Marie, Pearson, John V., Waddell, Nicola, Grimmond, Sean M., Dobrovic, Alexander, Bowtell, David D.L., Harnett, Paul R., deFazio, Anna, Bowtell, D., Chenevix-Trench, G., Green, A., Webb, P., DeFazio, A., Gertig, D., Traficante, N., Fereday, S. ... Zeps, N. (2018). BRAF mutations in low-grade serous ovarian cancer and response to BRAF inhibition. JCO Precision Oncology, 2 (2), 1-14. doi: 10.1200/PO.17.00221
2018
Conference Publication
How the rare see their care: Perceptions of care and patient reported outcomes in people living with neuroendocrine tumours
Wyld, D., Burge, M., Dumbrava, M., Callum, J., Neale, R. and Beesley, V. (2018). How the rare see their care: Perceptions of care and patient reported outcomes in people living with neuroendocrine tumours. Victorian Cancer Survivorship Conference, Melbourne, Australia, 8 -9 February 2018.
Supervision
Availability
- Associate Professor David Wyld is:
- Available for supervision
Looking for a supervisor? Read our advice on how to choose a supervisor.
Supervision history
Completed supervision
-
2020
Master Philosophy
Predictors of dosimetry and outcome to peptide receptor radionuclide therapy in metastatic neuroendocrine tumour.
Principal Advisor
Other advisors: Professor David Pattison
-
2021
Doctor Philosophy
Targeting receptor activator of NF-kB pathways in combination immunotherapy
Associate Advisor
Media
Enquiries
For media enquiries about Associate Professor David Wyld's areas of expertise, story ideas and help finding experts, contact our Media team: